logo

CN | EN
zhongyou
资讯分类
zhongyou
123
Wuhan ZhongYou Pharmaceutical Co., Ltd
 
123
Add: 28 chuangye avenue, gedian development zone
 
123
Tel: 0711-5920666
 
123
Fax: 0711-5920600
 
-
COMPANY NEWS
11-22

Development of lipid-lowering drugs continue to hot regulatory approval to shift to the end of the disease

The recent development of lipid-lowering drugs is very popular. A new lipid-lowering drug ETC-1002 from Esperion Therapeutics not only outperformed Merck's Zetia (generic name: Ezetimibe) in a mid-ter
11-22

Development of lipid-lowering drugs continue to hot regulatory approval to shift to the end of the disease

The recent development of lipid-lowering drugs is very popular. A new lipid-lowering drug ETC-1002 from Esperion Therapeutics not only outperformed Merck's Zetia (generic name: Ezetimibe) in a mid-ter
11-22

A breakthrough in stem cell research progresses in the cure or re-emergence of diabetes

DouglasMelton,adevelopmentalbiologistattheStemCellResearchInstituteatHarvardUniversity,andcolleaguesrecentlyreportedanewtechniqueinthejournalCelltosuccessfullytransformhumanembryonicstemcells(ESC)orin
11-02

Relationship between cholesterol synthesis / uptake markers and efficacy of atorvastatin in lowering cholesterol

InNovember2013,QiYueandZhaoDongfromBeijingAnzhenHospital,CapitalUniversityofMedicalSciences,conductedastudytodeterminewhetherthecholesterolsynthesis/absorptionstatuscouldinfluencethecholesterol-loweri
11-22

A breakthrough in stem cell research progresses in the cure or re-emergence of diabetes

DouglasMelton,adevelopmentalbiologistattheStemCellResearchInstituteatHarvardUniversity,andcolleaguesrecentlyreportedanewtechniqueinthejournalCelltosuccessfullytransformhumanembryonicstemcells(ESC)orin
Previous page
1
TCX

WeChat

TCX

Mobile web site

Contact us

Tel:0711-5920666
Fax:0711-5920600

E-mail:business@zypharma.net

Add:28 chuangye avenue, gedian development zone

Copyright©2019 Wuhan ZhongYou Pharmaceutical Co., Ltd.

 鄂ICP备12014712号      Design  By 300.cn